|Press Releases Detail:
AVITAR staffs Sales Team in support of Substance Abuse Testing Product Line.
January 04, 2000
CANTON, MA, JANUARY 4, 2000 – Avitar, Inc., (NASDBB:AVIT.OB) has appointed J. Michael Kutrik, III and Kenneth J. Kelly as Regional Sales Managers for its Southeast and East regions, respectively. The new hires are part of the company’s first hiring wave to support sales of its substance abuse testing product line. Avitar was the first to bring an oral-fluid based rapid substance abuse screening device to the market when it launched ORALscreen TM in April 1999. Avitar markets ORALscreen and its complementary product portfolio to the public safety industry and corporations.
"We’re excited to welcome these gentlemen to the Avitar team. They are both high-achievers with proven track records and strong experience in the drug testing industry," said Peter P. Phildius, chief executive officer and chairman of Avitar.
J. Michael Kutrik, III has six years of experience in sales for laboratory services leader SmithKline Beecham and a sales career of over ten years. Kenneth J. Kelly has served over twenty years in field and sales management positions, including experience selling a hair-based substance abuse testing service.
Avitar, Inc., headquartered in Canton, Massachusetts, develops, manufactures and markets innovative medical devices based on core technologies in oral fluid diagnostics and customized polyurethane applications. The company markets a unique portfolio of substance abuse testing products and services that includes the first point-of-contact rapid oral fluid screening device for drugs of abuse. Avitar also markets an oral fluid collection system for DNA testing as well as a proprietary line of polyurethane-based high tech medical devices. For more information, see Avitar’s Web Site at www.avitar.com
This release forward looking statements that are subject to risks and uncertainties, including the development and marketing of new applications that are detailed from time to time in the Company’s filings with the Securities and Exchange Commission.